CRPC

7 registered clinical trials studyying CRPC — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Castrate Resistant Prostate Cancer Enhertu Therapy NCT06610825	Washington D.C. Veterans Affairs Medical Center	Phase 2
Recruiting	A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682	Jacobio Pharmaceuticals Co., Ltd.	Phase 1 / Phase 2
Completed	A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal NCT02259114	Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 1
Active Not Recruiting	A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Inj NCT02266745	Promontory Therapeutics Inc.	Phase 2
Completed	A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer NCT02361086	Innocrin Pharmaceutical	Phase 1 / Phase 2
Completed	A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspe NCT01812746	BIND Therapeutics	Phase 2
Completed	A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer NCT02012920	Innocrin Pharmaceutical	Phase 2